Who is at risk of vascular Behçet’s? 🤔
📌 15% develop vascular involvement
📌 Mostly venous (DVT, thrombophlebitis)
📌 Often recurrent & multi-vessel
💡 Key predictors:
👨 Male sex
👁️ Ocular onset
👉 Think early risk stratification
🔗https://t.co/MO35LSmjhP
🧬 Rheumatoid nodules can be refractory—or even worsen—despite good joint control in RA.
📉 New case evidence shows cutaneous & pulmonary nodule regression with upadacitinib
➡️ Suggesting JAK inhibition effects beyond synovitis
🔗https://t.co/0egvaMkE8T
Today is #WorldArthritisDay2025, let’s dream together for a better future for everyone in the rheumatic and musculoskeletal diseases (#RMDs) community.
Share your dream with the #EULAR community and help turn hope into action!
#RMDreams#EULAR # EMEUNET #WorldArthritisDay
🚨 Join us for the upcoming EULAR–EMEUNET webinar:
"From Gut to Joint – Essential Insights for Rheumatologists & Gastroenterologists"
📅 9 Sept 2025 | 🕖 19:00–20:00 CEST
🔗 Register: https://t.co/hTX2qr5xFL
#Rheumatology#IBD#EULAR#EMEUNET
We’re excited to celebrate the Top 12 of the EMEUNET RheumaVision contest! 🏆✨
Let’s give them a huge round of applause and wish them the best of luck in the next stage of the competition!
Be watchful for the Individual videos of the semi-finalists in the next days!!
Meet Rheumavision Semi-Finalist Margarida Lucas Rocha and her presentation 'Neurological Involvement in Behçet's Disease' 👏👏👏
Full version: https://t.co/w3RlUKd7hQ
Please don't forget to show your support by likes and comments!!!
All the luck for the finals Margarida 🤞🤞🤞
Congratulations to @EUSTAR_org for putting an excellent course in Bordeaux, France. @Worldsclerofnd@delgaldoFrances@srfcure Great to see the dedication of the EUSTAR for training the next group of scleroderma researchers!
O frio chegou! Se vive com doenças reumáticas, já sentiu um aumento das dores?
Embora o frio não cause doenças reumáticas, ele pode intensificar as dores e o fenómeno de raynaud
Assista à entrevista do Prof. Doutor Fernando Pimentel
https://t.co/TyT9z1yRdM
Full Read Overview of the safety of bDMARDs/tsDMARDS - contraindications, precautions, & boxed warnings for treatment of RA, PsA, SpA, JIA - safety checklist for a class of drugs you use and diseases you treat https://t.co/5chrS3sW8i
🎉 The International Congress on Spondyloarthritides starts this week!
🌟 We are excited to hear the latest news about ASAS research projects including D2M-axSpA, ASAS-perSpA, ASAS-HI and others
👉 https://t.co/xAfeuwizXV
#Spondyloarthritis#Rheumatology#ASAS
📑 Don't miss out - register to receive access to this ebook on #vasculitis , with cutting-edge content from our leading titles. Stay ahead in your knowledge and practice! #rheumatology 👉 https://t.co/eskQKDN8qC
Happy to share the First Portuguese Recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases in @ARPrheumatology
https://t.co/ekeUpB4SRi
#EscleroseSistémica#SystemicSclerosis
✅ Efficacy and safety of targeted therapies 🎯 in #VEXAS syndrome: retrospective study from the FRENVEX group ⬇️ is just published in @ARD_BMJ 👍
https://t.co/y7GA5yEfbh